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The majority of aneuploid fetuses are spontaneously miscarried. Nevertheless, some aneuploid individuals survive despite
the strong genetic insult. Here, we investigate if the survival probability of aneuploid fetuses is affected by the genome-wide
burden of slightly deleterious variants. We analyzed two cohorts of live-born Down syndrome individuals (388 genotyped
samples and 16 fibroblast transcriptomes) and observed a deficit of slightly deleterious variants on Chromosome 21 and de-
creased transcriptome-wide variation in the expression level of highly constrained genes. We interpret these results as sig-
natures of embryonic selection, and propose a genetic handicap model whereby an individual bearing an extremely severe
deleterious variant (such as aneuploidy) could escape embryonic lethality if the genome-wide burden of slightly deleterious
variants is sufficiently low. This approach can be used to study the composition and effect of the numerous slightly dele-
terious variants in humans and model organisms.
[Supplemental material is available for this article.]
The majority of miscarriages are selective, i.e., contain chromo-
somal abnormalities or other severe mutations (Forbes 1997;
Larsen et al. 2013). However, little is known about why fetuses
with the same severe de novo variant can be either viable (at
term) or not (miscarried). We hypothesize that the outcome is in-
fluenced by the burden of slightly deleterious variants (SDVs).
Every human genome carries at least 1000 SDVs, including several
loss-of-function variants (Kaiser et al. 2015), dozens of exon-inter-
secting copy number variants (Sudmant et al. 2015), hundreds of
single-nucleotide missense coding substitutions (Xue et al. 2012;
Henn et al. 2016), and thousands of single-nucleotide regulatory
variants (Gulko et al. 2015). Numerous studies have demonstrated
that this burden of SDVs is under purifying selection in the human
population (Männik et al. 2015; Sulem et al. 2015; Narasimhan
et al. 2016; Sohail et al. 2017) and thus might affect fetal viability.
In this study, we focus on trisomy 21 (T21). T21 fetuses have
extremely high (up to 80%) miscarriage rates (Nussbaum et al.
2004), which may indicate strong embryonic selection. We hy-
pothesize that as a result of this selection, live-born T21 individu-
als possess a reduced burden of SDVs compared to live-born,
euploid control individuals. We hypothesized that a substantial
fraction of the SDVs interacts with trisomy, so that their preva-
lence differs between T21 and euploid individuals. Although the
SDVs on Chromosome 21 may directly affect the genes mapping
on this chromosome, interactions may also involve genes else-
where in the genome. We provisionally categorized SDVs into
directly and indirectly interacting with trisomy on the basis of
their genomic location: We assumed that Chromosome 21 SDVs
are directly interacting, whereas the SDVs on all other autosomes
may only be indirectly interacting.
In this study, we observed several lines of evidence, which is
in line with embryonic selection of T21 individuals acting against
a burden of SDVs. Based on our findings, we formulated the genet-
ic handicapmodel, stating that an individual bearing an extremely
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severe deleterious variant (i.e., genetic handicap) might escape
embryonic lethality if the genome-wide burden of SDVs is suffi-
ciently low.
Results
Genomic and transcription variation of genes encoded
on Chromosome 21 in T21 individuals
Functionally constrained Chromosome 21 genes demonstrate <1.5-fold
increased expression in T21 individuals
T21 fetuses with a relatively reduced expression of Chromosome
21 genes (<1.5-fold increase) might be favored by embryonic selec-
tion and thus have a higher probability of being live-born (Fig. 1A;
Antonarakis et al. 2004; Aït Yahya-Graison et al. 2007; Prandini
et al. 2007; Biancotti et al. 2010).We tested this by analyzing fibro-
blast transcriptomes of 16 T21 and 11 control live-born individu-
als. We used a set of Chromosome 21 genes (N = 233) that were
expressed in all 27 samples. For each gene, we estimated the
mean expression level in T21 and controls and computed a ratio
of these values (Fig. 1B). Themedian of the ratios was 1.473, which
does not significantly differ from the expected 1.5 (P-value = 0.78,
one-sample Wilcoxon signed rank test with μ = 1.5). However,
when we focused on a subset of functionally constrained genes
(highly expressed and essential, N = 23) (Methods), the median
of the ratios was significantly lower as compared to the whole set
of Chromosome 21 genes (1.379 versus 1.473, P-value = 0.035,
Mann-Whitney U test) (Fig. 1B), and the deviation from the ex-
pected 1.5 was also significant (P-value = 0.020, one-sample
Wilcoxon signed rank test with μ = 1.5) (Fig. 1B).
The <1.5-fold increase in the expression of functionally con-
strained genes is compatible with two explanations: (1) It might be
the effect of embryonic selection against T21 fetuses with high
overexpression of these genes; or (2) it might reflect a buffering
of trisomyby a regulatory network. In order to distinguish between
these two possibilities, wenext analyzed the genetic component of
the expression variation.
Regulatory variants of Chromosome 21 genes tend to diminish their
overexpression in T21 individuals
Inter-individual gene expression variation is associated with sin-
gle-nucleotide regulatory variants—expression quantitative trait
loci in cis (cis-eQTLs) (Montgomery and Dermitzakis 2011).
Therefore, regulatory variants that increase expression of Chromo-
some 21 genes (gain of expression [GOE] cis-eQTLs) may aggravate
the effect of trisomy 21; in contrast, regulatory variants that
decrease the expression of Chromosome 21 genes (loss of expres-
sion [LOE] cis-eQTLs) may partially compensate the trisomy 21 ef-
fect and be favorable. The embryonic selection eliminating such
GOE and retaining LOE cis-eQTLs would result in a <1.5-fold in-
crease in the expression of Chromosome 21 genes.
To functionally annotate GOE and LOE alleles on Chromo-
some 21, we analyzed the cis-eQTLs detected in three cell types (fi-
broblasts, lymphoblastoid cell lines, and T-cells) derived from
umbilical cords of 195 unrelated healthy European newborns
(The GenCord collection) (Dimas et al. 2009; Gutierrez-Arcelus
et al. 2013). Since the umbilical cord is a fetal tissue and we are in-
terested in embryonic selection, this collection of cis-eQTLs is rel-
evant for our analyses. For each Chromosome 21 cis-eQTL, we
polarized alleles as ancestral (A) or derived (D) using ancestral allele
information from The 1000 Genomes Project Consortium (2010)
and annotated derived alleles as GOE and LOE cis-eQTLs (Fig.
1C, upper). We assumed that the direction of the derived allele
in trisomic cases is the same as in disomic, i.e., if D is annotated
in the GenCord collection as GOE, the expression levels would
be ordered as AAA < AAD<ADD<DDD (Fig. 1C, lower). We only
used concordant (i.e., with the same direction) cis-eQTLs detected
in more than one cell type.
We then analyzed the genotype frequencies of the annotated
cis-eQTLs in a population of unrelated live-born T21 individuals
(N = 338). For the 63 annotated cis-eQTLs on Chromosome 21
(32 GOE and 31 LOE), we compared the observed and predicted
(Methods) frequencies of the DDD genotypes. Due to the small
sample size, we did not split the cis-eQTLs according to the proper-
ties (functionally constrained and functionally nonconstrained)
of associated genes. Our null expectation is that excess and deficit
of different genotypes is independent of the effect of regulatory al-
leles (Fig. 1D, dotted line). However, we observed that themajority
of LOEDDDgenotypes (22 of 32) have a higher frequency than ex-
pected, whereas the majority of GOE DDD genotypes (19 of 31)
have a lower frequency than expected (N = 63, Fisher’s odds ratio
= 3.41, P = 0.023) (Fig. 1D). Interestingly, if we further restrict our
analysis only to those cis-eQTLs that were concordant in all three
cell types of the GenCord collection, the signal becomes stronger,
although less significant due to the small sample size (N = 16,
Fisher’s odds ratio = 7.63, P = 0.118). We conclude that the distri-
bution of LOE and GOE cis-eQTLs (Fig. 1D) in live-born T21 indi-
viduals is compatible with embryonic selection favoring decreased
gene expression level of trisomic genes.
Deviation of Chromosome 21 alleles from the Hardy–Weinberg Equilibrium
uncovers signatures of selection
We next aimed to estimate the effect of all potentially deleterious
variants on Chromosome 21. Rare derived alleles are enriched in
deleterious variants (MacArthur et al. 2012; Fu et al. 2013), allow-
ing us to use them as a proxy for SDVs. Correspondingly, strong se-
lection driven by trisomy 21 will result in a deficit of rare derived
alleles.
To test this, we analyzed a European cohort of 338 unrelated
genotyped individuals with trisomy 21 (Sailani et al. 2013). If the
parents of T21 individuals represent a random subset from a pop-
ulation in the Hardy–Weinberg equilibrium, trisomic genotype
frequencies of Chromosome 21 single-nucleotide polymorphisms
(SNPs) can be predicted fromallele frequencies observed in the T21
cohort and the type of nondisjunction of Chromosome 21.
Nondisjunction of Chromosome 21 can occur at meiosis I or mei-
osis II, leading to different relationships between allele and geno-
type frequencies (Methods). Fitting observed and expected
numbers of genotypes in our analyzed population (Methods), we
estimated that the fraction of T21 individuals resulting from non-
disjunction in meiosis I is 74%, which is in agreement with a pre-
viously published ratio (Methods; Antonarakis et al. 1992). With
the estimation of this fraction, we were able to reconstruct the
number of expected genotypes (AAA, AAD, ADD, DDD, where
“A” denotes the ancestral allele and “D” denotes the derived allele)
for each allele based on its frequency (Fig. 2A).
First, for each of the 8929 SNPs on Chromosome 21, we com-
pared the number of observed and expected genotypes.Wedid not
find any SNPs with a significant difference between observed and
expected genotype frequencies (Bonferroni-corrected P-values >
0.01, Fisher’s exact test), indicating that the potential compensato-
ry selection, if it occurs, is not based on a single SNP with a strong
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effect, but ratheronmanySNPswith small effect. Thus, there areno
strong outliers from the expected distribution shown in Figure 2A.
Despite the fact that there are no significantly deviating indi-
vidual alleles, we have observed a substantial variation: Some ge-
notypes are in deficit (below the curve), whereas others are in
excess (above the curve) as compared to the expectation (Fig.
2A). In order to uncover a potential effect of selection acting on
many low-effect-size variants, we focused on this variation: If
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Figure 1. T21-specific variants: Expression level of Chromosome 21 genes is lower than expected. (A) Potential transcriptome signature of T21-specific
selection: T21 fetuses with decreased expression level of Chromosome 21 genes are expected to have an advantage during embryogenesis. (B) Less than
1.5-fold increase in the expression level of highly constrained Chromosome 21 genes. Relative increase in the expression level of 233 Chromosome 21
genes in their trisomic (3N) state does not significantly differ from 1.5. However, for a subset of 23 highly functionally constrained genes, the increase
in the expression level is lower than the expected 1.5. (∗) P-value < 0.05. (C ) A scheme defining loss of expression (LOE) and gain of expression (GOE)
cis-eQTLs (upper) and our extrapolation of the effects of cis-eQTLs to the triploid case (dark gray box plots on lower panel). (D) Regulatory variants can
compensate the overexpression of Chromosome 21 genes. The dotted line represents our expectation if the excess/deficit of genotypes is independent
of the direction of expression changes (GOE or LOE). However, in the T21 live-born cohort, we observed an excess of homozygotes for the loss of expression
derived alleles (LOE DDD) and a deficit of homozygotes for the gain of expression derived alleles (GOE DDD). (∗) P-value < 0.05.
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selection is responsible for some of these deviations, we expect
that the deficit of certain genotypes would be associated with in-
creased constraints of the nucleotides. We used the Genomic
Evolutionary Rate Profiling (GERP) score (Davydov et al. 2010) to
approximate the evolutionary constraints on each nucleotide
and binned SNPs into percentiles according to their derived allele
frequencies, yielding 100 bins with 89 SNPs in each. Next, in each
bin we characterized all genotypes in deficit and genotypes in ex-
cess by the median values of the corresponding GERP scores.
Finally, for each bin we computed the ratio of medians [median
(GERP score of alleles with a deficit of observed genotypes)/medi-
an(GERP score of alleles with an excess of observed genotypes)]
which is expected to be one under the null hypothesis. For the
AAD, ADD, and DDD genotypes, the ratios were indistinguishable
from 1 (P-value > 0.2, one-sample Wilcoxon signed rank test with
μ = 1; P-value is adjusted for multiple tests using Bonferroni correc-
tion). However, for the AAA genotype the ratio was greater than 1
(AAA: Bonferroni adjusted P-value = 0.0026, median = 1.26; one-
sample Wilcoxon signed rank test with μ = 1), suggesting that
more constrained SNPs (with high
GERP scores) might be associated with
deficient genotypes. If the observed ef-
fect is a result of selection, we expect
that the stronger the deviation from the
expectation, the higher the GERP score
in deficient genotypes. Thus, we repeated
our analysis taking into account only
SNPs with genotypes deviating (de-
creased or increased) by >5% from the
expectation. Indeed,we observed a stron-
ger effect for both homozygous geno-
types (AAA: Bonferroni adjusted P-value
= 0.005, median = 1.44; DDD: Bonferroni
adjusted P-value = 0.027, median = 1.29;
one-sample Wilcoxon signed rank test
with μ = 1), but did not observe this for
heterozygous genotypes (Bonferroni
adjusted P-values > 0.4; median = 1.02
[ADD] and 0.74 [DDD]; one-sample
Wilcoxon signed rank test with μ = 1).
The observed deficit of homozygous
genotypes corresponding to highly con-
strained nucleotide positions is compati-
ble with purifying selection against
many slightly deleterious alleles. More
pronounced selection against triploid
homozygous genotypes might be the re-
sult of dosage effect, whereas in the het-
erozygotic state, the increased ploidy
might be buffered by the presence of
two different alleles. Interestingly,
when we performed the same analysis
for the rest of the autosomes (all auto-
somes but Chromosome 21), we did not
observe any significant GERP differences
between genotypes in deficit and in ex-
cess (all P-values for AA, AD, and DD ge-
notypes > 0.15; one-sample Wilcoxon
signed rank test with μ = 1). This result
suggests that SNPs on Chromosome 21
are under the most stringent purifying
selection due to the trisomy.
In the previous analysis, we did not observe any associations
between the derived allele frequency and the ratio of GERP medi-
ans for all four genotypes (AAA, AAD, ADD, DDD; all P-values >
0.1, rank correlation). Because rare derived alleles are enriched in
deleterious variants, another test of a potential selection might
be a comparison of the expected and observed genotypes from
the point of view of the derived allele frequency. To do this, we
used the symmetry of the Hardy–Weinberg equilibrium (Fig. 2A),
inwhich the number of DDDgenotypes was expected to be similar
to the number of AAA genotypes when comparing alleles of the
same frequency [freq(D) = freq(A)]. First, we compared the frac-
tions of DDD and AAA genotypes among rare derived (with DAF
< 0.03) and rare ancestral (with DAF > 0.97) alleles (derived and an-
cestral alleles have similar distributions of frequencies, P-value >
0.8, Mann-Whitney U test). As expected, we did not observe
DDD and AAA genotypes for the majority of these alleles in our
T21 cohort (Fig. 2C, mosaic-plot); however, the fraction of the ob-
served DDD genotypes was lower as compared to the AAA geno-
types (P-value = 0.047, odds ratio = 0.46, Fisher’s exact test).
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Figure 2. Hardy–Weinberg distribution of Chromosome 21 alleles and signatures of selection in the
live-born T21 cohort. (A) Hardy–Weinberg distribution for trisomic alleles. The four curves represent
the expected relationships between allele frequencies and genotype frequencies, assuming that the frac-
tion of T21 individuals coming from nondisjunction in meiosis I is 74%. All dots are empirical observa-
tions. (B) The deficit of homozygous genotypes AAA and DDD is associated with increased
evolutionary constraints of the corresponding nucleotide positions. Taking into account the genotypes
in deficit and in excess (deviating by >5% from the expectation), we analyzed the GERP scores of the cor-
responding nucleotide positions. For each percentile of the derived allele frequency, we obtained the ra-
tio of the median GERP scores for nucleotides associated with a deficit or an excess of genotypes. Violin
plots reflect the distribution of these ratios for each genotype. In the case of AAA and DDD, the distribu-
tion of ratios has medians higher than the expected one: (∗) P-value < 0.05; (∗∗) P-value < 0.01. (C )
Homozygotes for rare derived alleles (DDD) are rarer than the homozygotes for rare ancestral alleles
(AAA) with the similar allele frequency: analysis of the two opposite tails of the Hardy–Weinberg distribu-
tion. (D) Observed homozygotes for rare derived alleles (DDD) are rarer than the observed homozygotes
for rare ancestral alleles (AAA) with the same allele frequency: analysis of the 500 allele pairs, matched by
allele frequency and characterized by the nonzero number of the observed homozygous genotypes. The
distribution of the log2(DDD/AAA) has the median (−0.193) which is lower than the expected zero.
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Second, to focus the analysis on the observed DDD and AAA geno-
types, we analyzed 500 allele-frequencymatched DDD–AAA geno-
type pairs (Methods). We found a significant deficit of DDD versus
AAA genotypes (P-value = 5.409 × 10−5, paired Mann-Whitney U
test) (Fig. 2D), confirming the deficit of homozygotes for rare de-
rived alleles in the T21 cohort. Interestingly, using the same ap-
proach for all autosomes except Chromosome 21, we did not
detect significant differences between DD and AA genotypes, em-
phasizing oncemore the most important role of the Chromosome
21 variability in the live-born trisomy. The Hardy–Weinberg equi-
librium on Chromosome 21 alleles (Fig. 2A) allowed us to uncover
nonuniformdistribution ofGERP scores (Fig. 2B) as well as a deficit
of homozygotes for rare derived alleles (Fig. 2C,D). Both of these
findings uncover signatures of potential purifying selection target-
ing many low-effect-size variants. Altogether, the preceding three
analyses are consistent with selection against T21 fetuses with an
excess of directly interacting deleterious variants.
Whole-transcriptome perturbations in T21 individuals
The deviations from the median gene expression might be delete-
rious, so that individuals whose gene expression level is too high
or too low are less fit. This assumption is consistent with several
lines of evidence: Both overexpression and underexpression
of genes have been associated with pathological conditions
(Carmona-Mora and Walz 2010; Jacquemont et al. 2011; Adamo
et al. 2015;McCoy et al. 2015); variation in gene expression affects
the severity of different mutations (Vu et al. 2015); increased vari-
ation in gene expression is associated with aging (Bahar et al.
2006; Végh et al. 2014) and low fitness (Wang and Zhang 2011);
single-nucleotide regulatory variants have a genome-wide distribu-
tion and population genetic properties similar to slightly deleteri-
ous variants (Popadin et al. 2013, 2014). If T21 fetuses with
nonoptimal (too lowor toohigh) gene expressionpatterns are pref-
erentially eliminated through miscarriages, we expect decreased
variation in gene expression among live-born T21 individuals as
compared to euploid controls (Fig. 3A). The transcriptome varia-
tion is expected to be deleterious for all fetuses, including euploid,
but the effectmight be exacerbated in T21 individuals.Wehypoth-
esize that the variationof gene expressionoutsideChromosome21
is involved in such indirect interactions with trisomy.
To test this, we used previously described transcriptome data
(fibroblast transcriptomes from 16 live-born T21 individuals and
11 controls). We selected 8781 genes that are expressed in all 27
samples, located on autosomes other than Chromosome 21, and
have similar expression level in T21 and control cohorts
(Methods). For each of these genes, we calculated the log ratio of
the coefficients of variation (CV) in expression level in T21 versus
control (Methods). We then performed 10,000 permutations, ran-
domly assigning 16 “T21” and 11 “controls” out of 27 samples,
and defined a test statistic (P-value) as the fraction of permuted
log ratios deviating from the observed value. Using vectors of
gene-specific P-values (N = 8781), we estimated the π1 statistics
(Supplemental Fig. S1A), which reflect the proportion of truly sig-
nificant P-values (Storey and Tibshirani 2003). Using π1 statistics
with different lambdas, we demonstrated that there is a group of
genes with significantly decreased expression variation in T21 ver-
sus controls (Methods; Supplemental Fig. S1). As the most conser-
vative estimation of the number of genes with decreased
expression variation in “T21” versus “controls,” we used π1 statis-
tics equal to 3% (Supplemental Fig. S1B, left) that corresponds to
250 genes. Importantly, when we estimated the opposite effect
(genes with increased expression variation in “T21” versus “con-
trols”) using the same approaches, we did not observe any such
genes (π1 = 0).
Fluctuations in gene expression affect the fitness according to
gene-specific expression constraints, which are related to gene age
(Popadin et al. 2014), gene essentiality (Georgi et al. 2013), hap-
loinsufficiency (Steinberg et al. 2015), and expression level (Wolf
et al. 2009). Thus, a subset of constrained genes might be the pri-
mary target of selection and show amore extreme reduction in ex-
pression variation in T21 versus controls. To test this, we grouped
all analyzed genes into categories defined by gene age, essentiality,
haploinsufficiency status, and expression level (Methods), and
compared the corresponding log ratios. Indeed, the constrained
groups of genes—old versus young, essential versus nonessential,
haploinsufficient versus haplosufficient, highly expressed versus
low-expressed—demonstrated a stronger reduction in expression
variation in T21 versus control (all P-values < 0.05, Mann-
Whitney U test) (Fig. 3B). Next, we grouped all genes according
to their number of constraints, from zero to four: zero if a gene is
neither old, essential, highly expressed, or haploinsufficient; four
if a given gene is in all four categories for constrained genes.Weob-
served that the more constrained groups are indeed characterized
by a higher fraction of genes with decreased expression variation
in T21 versus controls (Fig. 3C). For example, among themost con-
strained 2258 genes (with three and four levels of constraint), 11
genes have significantly lower variation in their expression level
in T21 versus control with FDR < 0.1, 121 genes with FDR < 0.15,
and 429 genes with FDR < 0.2 (Fig. 3C).
Recently, Sullivan et al. (2016) compared transcriptomes of
T21 individuals with sex- and age-matched controls using fibro-
blasts (six versus six) and lymphoblastoid cell lines (three versus
three). We repeated our gene expression variation analysis on this
independent data set. For each gene, we estimated the ratio of the
coefficients of variation between T21 and controls and derived
the P-values of the decreased variation in T21. Analyzing the distri-
bution of P-values, we observed a very similar trend to that de-
scribed in our main data set (N = 6069 genes; π1 statistics is
higher than zero, with lambdas changing from 0.05 to 1).
Moreover, for a subset of genes expressed in both our original
data set and in the data set of Sullivan et al. (2016) (N = 3536), we
observed a significant positive correlation between gene-specific
log ratios (Spearman’s ρ = 0.20, P-value < 2.2 × 10−16). Thus, genes
with decreased variance in T21 relative to controls tend to show
the same trend in both data sets. For the lymphoblastoid cell lines,
we did not observe any signals: The π1 statistic equals zero, mean-
ing that all P-values follow the Uniform (0,1) distribution.
The decreased variation in gene expression level in T21 versus
control individuals is compatible with a reduced burden of regula-
tory variants (both rare and common), which affect gene expres-
sion. This observation suggests that severe mutations, such as
trisomy 21, might be at least partially compensated by a decreased
genome-wide burden of indirectly interacting deleterious variants.
Genetic handicap hypothesis
If the biological fitness of an organism is determined by its muta-
tional burden (the total effect of all slightly, moderately, and se-
verely deleterious variants), we expect to observe a trade-off
between the presence of a severely deleterious mutation and the
number of SDVs. The term handicap, defined in the English
Oxford LivingDictionaries (2017) as “a circumstance thatmakes pro-
gress or success difficult,” has been used by Zahavi (1975) to refer
Embryonic selection of Down syndrome individuals
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to a phenotypically disadvantageous trait such that its presence is
themarker of a high genome quality of the carrier.We propose the
genetic handicap model, whereby an organism bearing a severely
deleterious mutation (a “genetic handicap” in Zahavi’s sense) is
only fit (i.e., viable at birth) if its genome-wide burden of SDVs is
sufficiently low (Fig. 4). The rationale for this hypothesis is that
only highly fit organisms, i.e., thosewith a sufficiently low burden
of SDVs, are able to tolerate the effects of severely deleterious
mutations and survive. Our approach resembles the “liability” in-
troduced by Falconer (1965) as a single continuous normally dis-
tributed factor representing a mixture of environmental and
genetic traits and determining the probability of acquiring a com-
plex disease. Here, we define genetic handicap as a severely delete-
rious mutation with very broad effect on cellular metabolism. The
broad effect assumes that the genetic handicap is unlikely to be
compensated/modified by a few variants, and therefore might
only be compensated by the genome-wide decreased burden of
slightly deleterious variants.
We assume here that embryonic viability is an important
component of fitness, so that the genetic handicap splits the af-
fected population into two groups: survivors at birth (handicap
carriers) and nonsurvivors (Fig. 4). If the increased number of
SDVs leads to a disproportional decline in fitness, which would
be the case, e.g., under truncation selection (Kondrashov 1988;
Crow and Kimura 2009), then handicap carriers will have a de-
creased number of SDVs as compared to controls (live-born organ-
isms without handicap) (Fig. 4). Moreover, we predict that the
more severe the genetic handicap, the higher the handicap effect
(difference in the mean numbers of SDVs between controls and
handicap carriers) (Fig. 4).
Discussion
In this report, we observed genomic and transcriptomic signatures
of embryonic selection in live-born individuals with Down syn-
drome. In these individuals, we found that SDVs are underrepre-
sented, and/or have a weaker phenotypic effect, suggesting that
more deleterious variants are being eliminated. These results are
consistent with the liability threshold/truncation selection model
involving synergistic epistasis between the genome-wide burden
of slightly deleterious variants (SDVs) and trisomy 21. Thus we
propose the genetic handicap model, which states that a severe
mutation (i.e., genetic handicap) might be partially compensated
by a reduced genome-wide burden of SDVs. In this case, the
B
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Figure 3. Live-born T21 individuals are closer to expression optimum in autosomal genes encoded outside Chromosome 21. (A) A schematic represen-
tation illustrating a potential effect of purifying selection against T21 fetuses with a nonoptimal pattern of expression during embryogenesis. The wide
distribution of genes with similar mean expression levels in T21 and control (C) cohort in early stages of embryogenesis (top) becomes narrower (bottom)
as a result of selection that eliminates low-fitness fetuses with excessively low or high expression level of genes. (B) The expression variation in T21 is de-
creased more in old versus young, haploinsufficient versus haplosufficient, essential versus nonessential, and highly expressed versus low-expressed genes.
(∗) P-value < 0.05; (∗∗) P-value < 0.01; (∗∗∗) P-value < 0.001. (C) The expression variation in the T21 cohort is decreased more in highly constrained genes.
The number of constraints, from zero to four: zero if the gene is neither old nor essential nor highly expressed nor haploinsufficient, and four if a given gene
has all four metrics for constrained genes.
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presence of a severemutation in a viable (fit) organismmight indi-
cate a reduced burden of SDVs.
From themedical point of view, future comparative investiga-
tions of the burden of SDVs in human genomes carrying a severe
mutation might shed light on (1) the difference between miscar-
ried and live-born individuals carrying the same genetic handicap;
(2) the extensive clinical heterogeneity often observed among live-
born individuals carrying identical severe mutations; and (3) the
relative impact of directly versus indirectly interacting SDVs.
From the evolutionary genetics point of view, one of the impor-
tant applications of the genetic handicap approach is the possibil-
ity of establishing qualitative and quantitative links between the
burden of SDVs and fitness. Within a given population, individu-
als differ in their fitness, defined as their relative reproductive suc-
cess (Haldane 1937). It has been
suggested that the genetic component
of this variation is predominantly due
to slightly deleterious variants (Muller
1950), which, contrary to strongly dele-
terious and beneficial variants, can segre-
gate within a population for a long time
and reach both relatively high frequen-
cies in a population and high numbers
in individual genomes (Crow 1958).
The functional relationship between the
burden of SDVs and fitness is of consider-
able importance for basic evolutionary
and medical genetics concepts, such as
the maintenance of intra-population
variation in fitness (Haldane 1937), evo-
lution of recombination and sexual selec-
tion (Kondrashov 1988; Agrawal 2001),
fitness landscapes, speciation, and spe-
cies extinction (Ohta 1992; Popadin
et al. 2007; Meer et al. 2010; Polishchuk
et al. 2015), inbreeding depression
(Charlesworth and Willis 2009), and
the etiology of complex diseases (Corto-
passi 2002).
Despite the fundamental impor-
tance of the relationship between SDVs
and fitness, there is no solid empirical
evidence regarding whether intra-popu-
lation fitness variation is driven by varia-
tion in the burden of SDVs. This is
because both the burden of SDVs is diffi-
cult to quantify, and fitness is one of the
most complex phenotypes to measure.
All apparently healthy people probably
carry thousand(s) of deleterious variants
in their genome; the unknown selection
coefficients associated with SDVs and
their epistatic interactions make it chal-
lenging to reconstruct fitness fromgenet-
ic data. For example, it is unknown
whether there is a difference in the bur-
den of SDVs between human popula-
tions (see the controversy in the
estimation of the burden in African and
non-African populations) (Lohmueller
et al. 2008; Fu et al. 2014; Simons et al.
2014; Do et al. 2015; Henn et al. 2016).
Important data on associations between SDVs and fitness in
humans come from genetic studies of complex diseases, in which
an increased burden of certain types of variants in affected versus
unaffected individuals has been demonstrated (Cooper et al. 2011;
Girirajan et al. 2011; Krumm et al. 2015). Recently, the genome-
wide burden of copy number variants (CNVs) (Männik et al.
2015) and runs of homozygosity (ROHs) (Joshi et al. 2016) have
been linked to fitness-related phenotypes (educational attain-
ment) among healthy individuals. More direct effects of ongoing
purifying selection in the healthy human population have been
shown recently as a deficit of loss-of-function (LoF) variants trans-
mitted from heterozygous parents to homozygous offspring
(Sulem et al. 2015) and of underrepresentation of individuals
with large numbers of LoF variants (Sohail et al. 2017). Although
A
B
C
Figure 4. The genetic handicap model. (A) The distribution of the number of SDVs in control (gray)
and affected (red) populations. The genetic handicap mutation (black arrow) is an equivalent of many
SDVs. (B) Truncation selection eliminates all organisms with the number of SDVs higher than the given
threshold (vertical black line) from both control and affected populations. (C) Handicap carriers have a
decreased number of SDVs (SDVs do not include the genetic handicap per se) than controls; this differ-
ence represents the handicap effect.
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these studies provide a first empirical correlation between the bur-
den of SDVs and fitness-related traits in human populations, they
are still restricted to a few types of variants/genes and would re-
quire large sample sizes to uncover the effects of slightly deleteri-
ous variants.
Additionally to direct inference of SDVs, fitness might be ap-
proximated through transcriptomic data (Marigorta et al. 2017).
The transcriptome can be considered as an intermediatemolecular
phenotype between DNA and organism-level phenotype.
Leveraging the transcriptome may have advantages over DNA se-
quencing because gene expression reflects complex interactions
between numerous DNA coding, DNA regulatory, and chromatin
variants. Gene expression level was shown to reveal minor differ-
ences between individuals and distinguish noncarriers, heterozy-
gous carriers, and patients homozygous for autosomal recessive
disorders (Cheung and Ewens 2006; Smirnov and Cheung 2008),
and the first two groups are phenotypically indistinguishable at
the organism level.
The genetic handicap approach described in this paper can
provide an a priori expectation for the difference in the burden
of SDVs between handicap carriers and controls, which might be
tested in empirical or experimental studies, and ultimately im-
prove our understanding and functional annotation of the numer-
ous slightly deleterious variants in humans and model organisms.
Methods
Transcriptome analyses
The primary skin fibroblast of 16 European unrelated T21 and 11
European unrelated control individuals stratified by sex and age
were described in Letourneau et al. (2014). To avoid batch effects,
T21 and control samples were randomized prior to culturing, RNA
extraction, and sequencing. All fibroblasts were grown in DMEM
media containing high glucose, GlutaMAX, and pyruvate (Life
Technologies 31966), and supplementedwith 10% fetal bovine se-
rum (Life Technologies 10270) and 1% penicillin/streptomycin/
fungizone mix (Amimed, BioConcept 4-02F00-H) at 37°C in a
5%CO2 atmosphere. Total RNAwas collected using TRIzol reagent
(Life Technologies 15596) according to themanufacturer’s instruc-
tions.mRNA-seq librarieswere preparedusing the IlluminamRNA-
seq Sample Preparation kit (RS-100-0801) and TruSeq RNA sample
preparation kit, according to the manufacturer’s instructions.
Libraries were sequenced on the Illumina HiSeq 2000 using
paired-end sequencing 2 × 100 bp. Reads were mapped against
the human (hg19) genome using the default parameters of the
TopHat mapper (Trapnell et al. 2009), filtering out multiple map-
ping reads, and FPKMs (fragments per kilobase of exon per million
fragments mapped) were calculated for each gene. Because se-
quence content is largely unchanged between hg19 and
GRCh38, especially for protein-coding genes, we argue that re-
aligning reads to GRCh38 would not significantly affect our re-
sults. No further normalization procedures were applied (such as
quantile normalization), because all analyses were run in the
gene-by-gene manner (however, see below for a test confirming
that quantile normalization does not affect results).
For whole-transcriptome analyses, we eliminated genes locat-
ed on sex chromosomes, Chromosome 21, and the mitochondrial
genome. We used a subset of genes expressed in all 27 samples
with FPKM> 0. In order to avoid any effects of differentially ex-
pressed genes, we only kept genes with a similar expression level
between T21 and controls, defined as 20% range of mean expres-
sion levels in control cohort: for each gene, mean(C) × 0.9≤
mean(Ts)≤mean(C) × 1.1.
For each gene, we estimated the coefficient of variation (CV)
as the ratio of the standard deviation to the mean separately for
T21 and control cohorts. Thereafter, we obtained the log ratio of
these coefficients as log2[CV(T21)/CV(C)].
To assess the significance of decreased expression variation in
T21 versus controls (P-values), we ran 10,000 permutations for
each gene. For a given gene, we compared the observed log ratios
obtained after randomly assigning 16 “T21” and 11 “control” la-
bels in a shuffled vector containing 27 expression levels of this
gene. Counting the fraction of permuted values, which are less
than the observed value,we approximated the P-value of decreased
expression variation of this gene in T21 cohort. It is important to
note, that this permutation analysis takes into account potential
outliers in our data set and thus assures that our results are robust.
Using our vector of gene-specific P-values, we estimated the π0 sta-
tistic and Q-values using the R package “qvalue” (Storey and
Tibshirani 2003). Thereafter, we obtained π1 as 1 − π0.
The coefficient of variation and the sample size are inversely
proportional. Thus, our log ratio can be partially affected by an in-
creased sample size of T21 cohort. Our permutation approach
overcomes this limitation by retaining the asymmetrical sample
size during the permutations (16 randomly assigned “Ts” versus
11 “control” labels), thus eliminating this potential bias. This per-
mutation analysis also refuses the possibility that our resultsmight
be driven by outliers (for example, by several too variably ex-
pressed control individuals).
To corroborate robustness of our results to normalization
steps, we reran our variation analysis using quantile normalized
FPKMs of 16 T21 and 11 controls (normalize.quantiles function
in the R package preprocessCore) (Bolstad et al. 2003). First, the
log ratio of the coefficients of variation of normalized data highly
correlated with the log ratio based on non-normalized data
(Spearman’s ρ = 0.91, P-value <2.2 × 10−16). Second, on normalized
data, we ran 10,000 permutations randomly assigning 16 “T21”
and 11 “Controls” out of 27 samples, and defined a test statistic
as the fraction of permuted log ratios less than or equal to the ob-
served value. Using this vector of gene-specific P-values (N = 8781),
we estimated the π1 statistic as 0.435, which is near identical to our
value 0.448 obtained for non-normalized data.
Gene age was used from Zhang et al. (2010), in which old or
young genes were defined as genes originating before or after the
divergence of zebrafish. Lists of essential and nonessential genes
have been used fromGeorgi et al. (2013). Haploinsufficiency score
was used according to Steinberg et al. (2015). Genes with a hap-
loinsufficiency score higher or lower than the median were
deemed haploinsufficient or haplosufficient. The expression level
of each gene was derived as the mean expression (FPKM) across all
27 samples. Genes with an expression level higher or lower than
median were called highly or lowly expressed genes. For analysis
of Chromosome 21 genes, those genes with an expression level
higher than the Chromosome 21–specific median were called
highly expressed genes.
Genotype analyses
The analyzed population, as well as the procedure for detecting
four clusters of genotypes (AAA, AAB, ABB, and BBB) for each trip-
loid SNP from Chromosome 21, were as in Sailani et al. (2013).
Hardy–Weinberg principle for trisomic cases
Nondisjunction of Chromosome 21 can occur at meiosis I or mei-
osis II, leading to different relationships between allele and geno-
type frequencies. In the case of meiosis I, the nondisjoining
parent may contribute gametes AA, AB, or BB with frequencies
Popadin et al.
8 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on June 4, 2018 - Published by genome.cshlp.orgDownloaded from 
p2, 2pq, and q2, leading to the next distribution of AAA, AAB, ABB,
and BBB genotypes as follows:
p3 + 3p2q+ 3q2p+ q3 = 1. (1)
In the case ofmeiosis II, the nondisjoining parent contributes
gametes AA and BB with frequencies p and q, leading to the next
distribution of AAA, AAB, ABB, and BBB genotypes as follows:
p2 + pq+ qp+ q2 = 1. (2)
Combining both Equations (1) and (2) yields
( p3 + 3p2q+ 3q2p+ q3)†X+ ( p2 + pq+ qp+ q2)†(1−X) = 1, (3)
where X is the fraction of T21 individuals, resulting from nondis-
junction at meiosis I. In order to estimate X in our data set of 338
T21, we estimated the differences in the observed and predicted
numbers of AAA, AAB, ABB, and BBB genotypes with X, changing
from 0.60 to 0.90 with step 0.01. We found that the predicted ge-
notype frequencies are closer to the observed values when X is
0.72–0.76. For our analyses, we used X = 0.74; however, all results
with X equal to 0.72, 0.73, 0.75, and 0.76 are qualitatively similar:
Figures 1D, and 2C and D, remain unchanged, whereas Figure 2, A
and B, remain very similar (there are no significantly deviating al-
leles on Fig. 2A; there is the same trend for AAA and DDD geno-
types on Fig. 2B).
It has been shown that 77.1% of maternal nondisjunctions
(128 out of 166) occurred in meiosis I; however, only 22.2% of pa-
ternal nondisjunctions (two of nine) occurred in meiosis I
(Antonarakis et al. 1992). Taking into account the prevalence of
maternal nondisjunctions, the average probability of nondisjunc-
tions inmeiosis I is 74% (130 out of 175), which is consistent with
our estimation.
Paired test of symmetry
Due to the small number of rare ancient (ancestral) alleles with
which to match pairs of alleles (one derived and once ancestral
with the same frequency), we started from the ancestral allele.
Each SNP was used only once, and the frequencies of alleles D
and A in each matched pair were the same (P > 0.2, paired Mann-
Whitney U test). This analysis is deterministic and consists of the
next steps: (1) We subset all rare ancestral alleles A [freq(A) < 0.1]
with at least one observed homozygous genotype AAA and sort
them according to the frequency of allele A; (2) we subset all rare
derived alleles D [freq(D) < 0.1] with at least one observed homozy-
gous genotype DDD and sort them according to the frequency of
allele D; (3) starting from the most rare ancestral allele we create
matched pairs: Find the derived allele with the same or the most
similar allele frequency; if there are several alleles D with identical
frequencies (this occurs in <10% of pairs) we take the most distant
one from the allele A, thematched alleleD is excluded from further
pairing; and (4) analysis stops at 500 matched pairs.
Direction of cis-eQTL derived alleles
We calculated the direction of effect of each cis-eQTL as previously
described (Popadin et al. 2014). We estimated the slope of a linear
model between the number of derived alleles (AA = 0, AD = 1,DD =
2) and the expression level of the exon used for the cis-eQTL call. If
a given cis-eQTL affected more than one exon, we used the direc-
tion of the strongest effect (with the highest absolute value of
the effect).
The congruent cis-eQTLs were defined as “+,+,+”; “+,+,0”; “−,
−,−”; and “−,−,0”; where “+,” “−,” and “0”means GOE, LOE, and
no detected cis-eQTLs in three cell type of the umbilical cord
collection.
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